ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

VRX Bausch Health Cos

23.40
0.00 (0.00%)
03 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Bausch Health Cos NYSE:VRX NYSE Ordinary Share
  Price Change % Change Share Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 23.40 0.00 01:00:00

Harwood Feffer LLP Announces Investigation of Synergetics USA, Inc.

02/09/2015 10:13pm

PR Newswire (US)


Valeant Pharma (NYSE:VRX)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more Valeant Pharma Charts.

NEW YORK, Sept. 2, 2015 /PRNewswire/ -- Harwood Feffer LLP (www.hfesq.com) is investigating potential claims against the board of directors of Synergetics USA, Inc. ("Synergetics" or the "Company") (NASDAQ: SURG) concerning the proposed acquisition of the Company by Valeant Pharmaceuticals International, Inc. ("Valeant") (NYSE: VRX).

Harwood Feffer LLP

Under the terms of the agreement between the companies, Valeant will promptly commence a tender offer to acquire all outstanding shares of Synergetics' common stock for $6.50 per share in cash plus one contingent value right entitling the stockholder to receive up to $1.00 per share if specified sales thresholds for Synergetics are achieved following the closing.

Our investigation concerns whether the Synergetics board of directors is fulfilling its fiduciary duties, maximizing the value of the Company, disclosing all material benefits and costs, and obtaining full and fair consideration for Company stockholders. 

If you own Synergetics shares and wish to discuss this matter with us, or have any questions concerning your rights and interests with regard to this matter, please contact:

James G. Flynn, Esq.

Robert I. Harwood, Esq.
Harwood Feffer LLP
488 Madison Avenue
New York, New York 10022
Phone Numbers: (877) 935-7400
(212)935-7400
Email: jflynn@hfesq.com
Website: http://www.hfesq.com 
Follow us on Twitter: @HarwoodFeffer

Harwood Feffer has been representing individual and institutional investors for many years, serving as lead counsel in numerous cases in federal and state courts. Please visit the Harwood Feffer LLP website (http://www.hfesq.com) for more information about the firm.

Attorney Advertising. The law firm responsible for this advertisement is Harwood Feffer LLP (www.hfesq.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Logo - http://photos.prnewswire.com/prnh/20120215/MM54604LOGO

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/harwood-feffer-llp-announces-investigation-of-synergetics-usa-inc-300137210.html

SOURCE Harwood Feffer LLP

Copyright 2015 PR Newswire

1 Year Valeant Pharma Chart

1 Year Valeant Pharma Chart

1 Month Valeant Pharma Chart

1 Month Valeant Pharma Chart

Your Recent History

Delayed Upgrade Clock